---
title: "Jiangsu Hengrui files HKEX next-day disclosure return after share repurchase for treasury shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295383271.md"
description: "Jiangsu Hengrui filed a next-day disclosure with the HKEX regarding the repurchase of 200,000 A shares on August 10. The buyback price ranged from RMB 53.65 to 54.2 per share, totaling RMB 10.78 million. These shares were acquired as treasury shares, with no shares cancelled."
datetime: "2026-08-10T09:16:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295383271.md)
  - [en](https://longbridge.com/en/news/295383271.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295383271.md)
generator: "portal-rs"
---

# Jiangsu Hengrui files HKEX next-day disclosure return after share repurchase for treasury shares

-   Jiangsu Hengrui filed a next-day disclosure return showing a repurchase of 200,000 A shares on Aug. 10. \* Buyback price range RMB 53.65–54.2 per share; aggregate price paid RMB 10.78 million. \* Shares were held as treasury shares; cancelled shares: 0. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangsu Hengrui Medicine Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260810-12278558), on August 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [600276.CN](https://longbridge.com/en/quote/600276.CN.md)

## Related News & Research

- [HENGRUI PHARMA  1H26 Net Profit Rises 0.3% YoY to RMB4.465 Billion; Shares Now Down Over 7%](https://longbridge.com/en/news/296422700.md)
- [Hengrui Pharma launches RMB 1 billion-RMB 2 billion A-share buyback, caps price at RMB 81.78](https://longbridge.com/en/news/296368941.md)
- [Hengrui Pharma Advances 2026 Employee Stock Ownership Plan Using Existing A Shares](https://longbridge.com/en/news/296370263.md)
- [Jiangsu Hengrui files HKEX next-day disclosure return reporting share repurchase at RMB 52.96](https://longbridge.com/en/news/294665198.md)
- [Fabricate Adds Database Explorer to Its Free AI Website Builder](https://longbridge.com/en/news/296641055.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**